Liquid Biopsy in Peritoneal Carcinomatosis from Colorectal Cancer: Current Evidence and Future Perspectives
Cancers · 26.04.2025 · 17 (9) · 1461
DOI: 10.3390/cancers17091461 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 26.04.2025. Verfasst von Valentino Martelli und 15 weiteren Autor:innen. Beteiligte Einrichtung: Medical Oncology Department, Hospital del Mar, Hospital del Mar Research Institute, Universitat Pompeu Fabra, Centro de Investigación Biomédica en Re…. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, Fundacion CRIS Excellence, International Cancer Foundation.
Abstract (Originalsprache)
Peritoneal carcinomatosis (PC) represents a challenge in the management of metastatic colorectal cancer (mCRC) because of the difficulties in diagnosis, tumor burden assessment, and in selecting the optimal treatments. A critical limitation is the lack of robust prognostic and predictive biomarkers, largely relying on serum markers (e.g., carcinoembryonic antigen) or the peritoneal carcinomatosis index (PCI) for disease extent. Circulating tumor DNA (ctDNA)—genomic fragments shed by tumor cells into the bloodstream—is now recommended by international guidelines for mCRC management. Its potential extends to PC, where it may enhance diagnostic, therapeutic, and follow-up strategies. However, PC from CRC (PC-CRC) is associated with lower ctDNA levels and detection rates compared to other metastatic sites, posing a challenge for its clinical utility. To address these limitations, peritoneal fluid analysis has emerged as a promising alternative, with peritoneal tumor DNA (ptDNA) detected at higher concentrations in this anatomical space. Integrating ctDNA and ptDNA may offer a deeper understanding of PC-CRC biology and provide more precise tools for managing this complex disease. This approach has the potential to revolutionize the treatment paradigm for PC-CRC, bringing precision medicine even to this subgroup of patients traditionally associated with poor outcomes. This review aims to evaluate the diagnostic, prognostic, and therapeutic implications of ctDNA and ptDNA in PC-CRC, highlighting current limitations and future directions.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical Oncology Department, Hospital del Mar, Hospital del Mar Research Institute, Universitat Pompeu Fabra, Centro de Investigación Biomédica en Red Cancer (CIBERONC), 08003 Barcelona, Spain.
- Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, 16133 Genova, Italy.
- Section of Colon and Rectal Surgery, Department of Surgery, Hospital del Mar, 08003 Barcelona, Spain.
- Pathology Department, Hospital del Mar, Hospital del Mar Research Institute, Universitat Pompeu Fabra, Centro de Investigación Biomédica en Red Cancer (CIBERONC), 08003 Barcelona, Spain.
- Cancer Research Program, Hospital del Mar Research Institute, 08003 Barcelona, Spain.
- Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori, 20133 Milan, Italy.
ORCID-Profile: Valentino Martelli, Joana Vidal, Sílvia Salvans, Marta Jiménez, Joan Gibert, Filippo Pietrantonio
Förderung
- Instituto de Salud Carlos III
- Fundacion CRIS Excellence
- International Cancer Foundation
- Instituto de Salud Carlos III—FEDER
- International Cancer Foundation—Clinical Unit Visit Fellowship
Zitieren
APA
Martelli, V., Vidal, J., Salvans, S., Fernández, C., Badia-Ramentol, J., Linares, J., Jiménez, M., Sibilio, A., Gibert, J., Pérez, M., Bellosillo, B., Calon, A., Pietrantonio, F., Iglesias, M., Pascual, M., & Montagut, C. (2025). Liquid Biopsy in Peritoneal Carcinomatosis from Colorectal Cancer: Current Evidence and Future Perspectives. Cancers, 17(9), 1461. https://doi.org/10.3390/cancers17091461
Vancouver
Martelli V, Vidal J, Salvans S, Fernández C, Badia-Ramentol J, Linares J, et al. Liquid Biopsy in Peritoneal Carcinomatosis from Colorectal Cancer: Current Evidence and Future Perspectives. Cancers. 2025;17(9):1461. doi:10.3390/cancers17091461
BibTeX
@article{Martelli2025,
author = {Martelli, Valentino and Vidal, Joana and Salvans, Sílvia and Fernández, Concepción and Badia-Ramentol, Jordi and Linares, Jenniffer and Jiménez, Marta and Sibilio, Annarita and Gibert, Joan and Pérez, Marina and Bellosillo, Beatriz and Calon, Alexandre and Pietrantonio, Filippo and Iglesias, Mar and Pascual, Marta and Montagut, Clara},
title = {Liquid Biopsy in Peritoneal Carcinomatosis from Colorectal Cancer: Current Evidence and Future Perspectives},
journal = {Cancers},
year = {2025},
volume = {17},
number = {9},
pages = {1461},
doi = {10.3390/cancers17091461}
}
EUVIMED